Fig. 3

The prognostic performance of the 4 pyroptosis-related gene signature in the training cohort and validation cohort. a The distribution of the risk scores in training cohort, (b) and in validation cohort. c The scatter plots showing whether the samples were alive or not in training cohort, (d) and in validation cohort. e Two-dimensional projection by a t-SNE analysis in training cohort, (f) and in validation cohort. g Score plot for the principal component analysis (PCA) in training cohort, (h) and in validation cohort. i Kaplan-Meier curves for the overall survival of patients in the high- and low-risk groups in training cohort, (j) and in validation cohort